Stoke Therapeutics, Inc.
Antisense oligomers and uses thereof
Last updated:
Abstract:
Provided herein are methods and compositions for increasing the expression of a protein, and for treating a subject in need thereof, e.g., a subject with deficient protein expression or a subject having a disease described herein.
Status:
Grant
Type:
Utility
Filling date:
13 Jun 2018
Issue date:
24 Aug 2021